CompoAtlas

Bell Bone Density With Calcium

Natural health product licensed in Canada

Licence holder
Bell Lifestyle Products Inc.
NPN or DIN-HM
80030388
Status
Active licence
Licence date
10 March 2012
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Indole-3-carbinol

Source : Synthétique

20 mgNot calculated
Cuivre

Source : Gluconate de cuivre (II)

500 mcg500 µg
Phosphore

Source : Phosphate de calcium

500 mg500,000 µg
Boron

Source : Citrate de bore

0.23 mgNot calculated
Medicago sativa

Source : Feuille

100 mgNot calculated
Calcium

Source : Carbonate de calcium

500 mg500,000 µg
Calcium

Source : Phosphate de calcium

500 mg500,000 µg
Calcium

Source : Citrate de calcium

500 mg500,000 µg

Non-medicinal ingredients

Gélatine, Eau purifiée

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedmaximum: 1 Capsulemaximum: 1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in the development and maintenance of bones. Helps in the development and maintenance of teeth. Helps in the absorption and use of calcium and phosphorus.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80030388

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line